Skip to main content
. 2021 Apr 6;30(7):e338–e343. doi: 10.1097/IJG.0000000000001847

TABLE 1.

Summary of PACTS Case Series

Patient Age (y) Procedure DOS Laser Date Time From XEN (mo) Preoperative IOP (mm Hg) Preoperative Medication Immediate Postoperative IOP (mm Hg) Last IOP (mm Hg) Time From Laser (MO) Post Gl Med Prior Ndl-ing Bleb Appear Post Laser Prior Surgery
Case 1 F/H POAG (3) 74 XAE OD 60 µg MMC 8/2019 09/2020 13 19 3 16 15 6 1 Y Moderateimprovement PTome
Case 2 F/C PXF (3) 78 XAE OS 50 µg MMC 5/2019 7/2020 14 16 4 8 10 8 2 N Moderateimprovement PTrab
Case 3 M/C POAG (3) 71 Phaco-XAI OS 70 µg MMC 12/2020 1/5/2021 1 25 0 13 11 1 1 N Moderateimprovement None
Case 4 F/C PXF (3) 90 XAE OD 80 µg MMC 8/6/2020 11/16/2020 3 and 6 52 and 41 0 15 16 16 16 3 1 0 0 Y Moderateimprovement Phaco
Case 5 M/I POAG (3) 76 XAI (2nd XEN) OS 20 µg MMC 8/2017 10/2020 38 48 1 14 12 3 1 N Marked improvement PhacoXEN
Case 6 M/AA POAG (3) 60 Phaco/XAE OD Open-conjunctival 60 µg MMC 9/2020 1/2021 4 28 4 23 23 1 4 Y Slight improvement None

C indicates Caucasian; DOS, date of surgery; F, female; Gl, glaucoma medications; H, Hispanic; I, Indian; IOP, intraocular pressure; M, male; MMC, mitomycin-C; MO, months following laser rescue; N, no; Ndl-ing, needling; OD, oculus dexter; PACTS, periluminal anterior chamber tip shock wave; Phaco, phacoemulsification; POAG, primary open angle glaucoma; PTome, phacotrabectome; PTrab, phaco-trabeculectomy; PXF, pseudoexfoliation; XAE, XEN ab-externo; XAI, XEN ab interno; Y, yes.